Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Pyxis Oncology (NASDAQ: PYXS) is a clinical-stage biotechnology company strategically focused on developing a diverse portfolio of next-generation therapeutics to combat difficult-to-treat cancers. Their core approach involves antibody-drug conjugates (ADCs) and novel immunotherapies designed to offer improved efficacy and tolerability. By targeting unique tumor biology and leveraging innovative platforms, Pyxis Oncology aims to significantly improve the quality of life for patients with various malignancies. The company is advancing multiple candidates through preclinical and clinical development.
Serves as the central hub for corporate leadership, research and development activities, clinical operations management, and administrative functions.
Modern laboratory and office spaces designed to foster collaboration and support cutting-edge biological research and drug development.
A dynamic, science-driven, and collaborative environment focused on innovation in oncology. Employees are typically passionate about advancing cancer treatments and work in a fast-paced, results-oriented setting.
Crucial for the company's strategic decision-making, execution of its R&D pipeline, and overall operational management as a clinical-stage biotechnology firm.
Pyxis Oncology is primarily based in the United States, with its headquarters in Waltham, MA, driving its research, development, and corporate strategy. While direct office presence internationally is not prominent, its clinical development programs for novel cancer therapeutics may involve collaboration with clinical trial sites and research partners globally to reach diverse patient populations and advance its pipeline.
35 Gatehouse Drive
Waltham
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Pyxis Oncology' leadership includes:
Pyxis Oncology has been backed by several prominent investors over the years, including:
In the past 12 months (June 2023 - May 2024), Pyxis Oncology has seen key leadership transitions, including the appointment of a new Chief Medical Officer and a new Chief Financial Officer.
Discover the tools Pyxis Oncology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for Pyxis Oncology likely follow standard corporate patterns. The most probable format uses the first initial followed by the last name.
[first_initial][last]@pyxisoncology.com
Format
jsmith@pyxisoncology.com
Example
80%
Success rate
GlobeNewswire via Pyxis Oncology • May 9, 2024
Pyxis Oncology announced its financial results for the first quarter ended March 31, 2024, and provided an update on its clinical programs and corporate milestones....more
GlobeNewswire via Pyxis Oncology • April 8, 2024
Pyxis Oncology presented promising preclinical data for its PYX-106 program, an anti-Siglec-15 antibody, at the American Association for Cancer Research (AACR) Annual Meeting 2024....more
GlobeNewswire via Pyxis Oncology • February 29, 2024
Pyxis Oncology reported its financial results for the full year ended December 31, 2023, and shared progress on its pipeline and strategic objectives....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Pyxis Oncology, are just a search away.